Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$4.1B
29M shares
52-week range
$112.09 – $249.56
19% from low
Sector
TOTALIZING FLUID METERS & COUNTING DEVICES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $433.7M | $424.6M | $425.5M | $505.2M | $565.6M | $703.6M | $826.6M | $916.7M |
| Cost of revenue | $271.4M | $261.1M | $257.3M | $299.7M | $345.6M | $427.2M | $497.4M | $534.6M |
| Gross profit | $162.3M | $163.5M | $168.2M | $205.5M | $220.0M | $276.4M | $329.2M | $382.1M |
| Gross margin | 37.4% | 38.5% | 39.5% | 40.7% | 38.9% | 39.3% | 39.8% | 41.7% |
| R&D | $11.1M | $11.9M | $11.6M | $14.7M | $15.8M | $19.0M | $19.2M | $0 |
| Operating income | $56.9M | $62.1M | $65.2M | $78.7M | $87.3M | $118.0M | $157.9M | $183.4M |
| EBITDA | $61.3M | $86.0M | $90.2M | $106.5M | $113.4M | $146.0M | $190.1M | $223.2M |
| Net income | $27.8M | $47.2M | $49.3M | $60.9M | $66.5M | $92.6M | $124.9M | $141.6M |
| Net margin | 6.4% | 11.1% | 11.6% | 12.1% | 11.8% | 13.2% | 15.1% | 15.5% |
| EPS (diluted) | 0.95 | 1.61 | 1.69 | 2.08 | 2.26 | 3.14 | 4.23 | 4.79 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $912M | $4.50 | $4.21–$4.89 | 7 |
| 2027 | $983M | $4.94 | $4.54–$5.37 | 7 |
| 2028 | $1.1B | $5.78 | $5.68–$5.97 | 4 |
| 2029 | $1.2B | $6.46 | $6.29–$6.60 | 2 |
Forward consensus · source: Financial Modeling Prep
Badger Meter is a provider of water management solutions. The company's solutions encompass measurement and control hardware, connectivity and communication, data visualization and software. Badger Meter has global operations, with the vast majority of revenue derived from the US.
www.badgermeter.comNo one on the platform currently holds BMI.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 199,200 | $30.3M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-22 | $0.4000 | 2026-06-05 |
| 2026-02-27 | $0.4000 | 2026-03-13 |
| 2025-11-21 | $0.4000 | 2025-12-05 |
| 2025-08-22 | $0.4000 | 2025-09-05 |
| 2025-05-23 | $0.3400 | 2025-06-06 |
| 2025-02-28 | $0.3400 | 2025-03-14 |
| 2024-11-22 | $0.3400 | 2024-12-06 |
| 2024-08-23 | $0.3400 | 2024-09-06 |
| 2024-05-23 | $0.2700 | 2024-06-07 |
| 2024-02-22 | $0.2700 | 2024-03-08 |
No one on the platform has traded BMI yet.
| $3.7B |
| — |
| LFUSLittelfuse, Inc. | $449.02 | -0.74% | $11.4B | — |
| NOVTNovanta Inc. | $157.75 | +0.12% | $5.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-11-22 |
| $0.2700 |
| 2023-12-08 |
| 2023-08-24 | $0.2700 | 2023-09-08 |
| Execution date | Ratio |
|---|---|
| 2016-08-29 | 2-for-1 |
| 2006-06-16 | 2-for-1 |
Trading at 30.5× earnings vs its 44.5× historical median P/E.
Fair value ≈ $201.91 · price $138.67 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Wall St is expecting 1.02 EPS for $BMI Q2 [Reporting 07/16 BMO] http://www.estimize.com/intro/bmi?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$BMI Added a bit to the core $BMI position a hair below the 50 and a 27ish FPE NFY, which is 13 points lower than it historically trades per Refinitiv. Nice to see this one recover into the Rut's rebalancing and congrats. to those who've held.
View on StockTwits ↗$BMI high quality biz with many insider purchases this year
View on StockTwits ↗$BMI $BMI is trading at 27 FPE NFY and 30 PE at the moment while the /NQs are down 800 points, the /RTY is down 20 and the /ES is down /80. I'm looking for a lower entry to add to a core position, but it's a low vol and doesn't always honor the trading ranges. TBD and wish me luck with that one.
View on StockTwits ↗Wall St is expecting 1.02 EPS for $BMI Q2 [Reporting 07/16 BMO] http://www.estimize.com/intro/bmi?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗Wall St is expecting 1.02 EPS for $BMI Q2 [Reporting 07/16 BMO] http://www.estimize.com/intro/bmi?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$BMI Share Price: $130.52 Contract Selected: Nov 20, 2026 $130 Calls Buy Zone: $12.92 – $15.96 Target Zone: $22.72 – $27.76 Potential Upside: 66% ROI Time to Expiration: 161 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗Wall St is expecting 1.02 EPS for $BMI Q2 [Reporting 07/16 BMO] http://www.estimize.com/intro/bmi?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.